Numeric Investors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Numeric Investors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$100K	Sell	1,186 -1,760	-60%	-$173K	﹤0.01%	1042
2017 Q3	$340K	Sell	2,946 -6,792	-70%	-$715K	﹤0.01%	960
2017 Q2	$1.14M	Buy	+9,738	New	+$1.21M	0.01%	650
2016 Q2	–	Sell	-3,711	Closed	-$347K	–	1210
2016 Q1	$347K	Buy	+3,711	New	+$404K	﹤0.01%	818
2015 Q4	–	Sell	-9,386	Closed	-$1.36M	–	1160
2015 Q3	$1.36M	Buy	9,386 +8,256	+731%	+$1.52M	0.02%	468
2015 Q2	$240K	Buy	1,130 +120	+12%	+$29.4K	﹤0.01%	816
2015 Q1	$234K	Buy	+1,010	New	+$244K	﹤0.01%	778

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Numeric Investors's BLCM Position: Q4 2017 in Review

Numeric Investors reduced its Bellicum Pharmaceuticals, Inc. (BLCM) stake by 60% in Q4 2017, selling an estimated $173K and leaving 1,186 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

Numeric Investors first reported a position in BLCM in Q1 2015 and has held it in 7 quarters since. The position peaked at $1.36M in Q3 2015. 91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.

Numeric Investors held 1,186 shares of Bellicum Pharmaceuticals, Inc. worth $100K as of Q4 2017.
Numeric Investors sold 1,760 Bellicum Pharmaceuticals, Inc. shares in Q4 2017, an estimated $173K.
Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1042 holding.
Numeric Investors first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and has held it in 7 quarters since.
Numeric Investors's Bellicum Pharmaceuticals, Inc. position peaked at $1.36M in Q3 2015.
91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.